Variceal Upper GI Bleeding — Acute Management

Key Points

• Start vasoactive therapy and antibiotic prophylaxis before endoscopy when variceal bleeding is suspected.
• Use a restrictive transfusion strategy in most stable patients; over-transfusion can increase portal pressure.
• Perform endoscopy after stabilization, generally within 12 hours.
• Endoscopic variceal ligation is first-line endoscopic therapy for esophageal variceal bleeding.
• Do not routinely correct cirrhotic INR to a normal value with fresh frozen plasma.
• Uncontrolled hemorrhage requires a bridge device or stent only while definitive rescue TIPS is mobilized.
• Selected high-risk patients benefit from preemptive TIPS early in the admission.
• After survival, secondary prevention requires nonselective beta blockade plus serial variceal ligation unless TIPS changes the strategy.

Algorithm

1. Stabilize airway and circulation, establish large-bore access, send crossmatch and baseline studies.
2. Begin vasoactive therapy and ceftriaxone or other appropriate antibiotic prophylaxis immediately.
3. Use restrictive red-cell transfusion while treating active shock according to physiology.
4. Perform upper endoscopy within about 12 hours after initial resuscitation.
5. Ligate bleeding esophageal varices; use gastric-varix-specific therapy when appropriate.
6. If bleeding persists, use temporary bridge control and arrange rescue TIPS.
7. Assess early for preemptive TIPS in high-risk patients even if initial endoscopic hemostasis succeeds.
8. After stabilization, initiate secondary prevention and optimize cirrhosis care, nutrition, encephalopathy management, and transplant evaluation.

Clinical Synopsis & Reasoning

Presentation includes hematemesis, coffee-ground emesis, melena, or less commonly hematochezia during brisk hemorrhage. In cirrhosis, assume portal-hypertensive bleeding is possible until endoscopy defines the source. Assess mental status, aspiration risk, blood pressure, orthostasis, perfusion, and signs of chronic liver disease. Hemoglobin can be initially misleading because equilibration takes time. Obtain CBC, metabolic panel, INR, fibrinogen when severe bleeding is present, type and crossmatch, and liver tests. Risk is driven by active hemorrhage, shock, hepatic reserve, renal dysfunction, infection, and encephalopathy. Intubation before endoscopy is reserved for patients with impaired airway protection, massive ongoing hematemesis, or severe encephalopathy; routine prophylactic intubation can cause complications. Correct profound thrombocytopenia or fibrinogen deficiency when clinically important, but do not attempt to normalize INR with plasma simply because cirrhosis has elevated INR. Distinguish variceal hemorrhage from peptic ulcer, portal hypertensive gastropathy, gastric antral vascular ectasia, malignancy, and other nonvariceal sources. Gastric varices require a different endoscopic or radiologic strategy from esophageal varices.

Treatment Strategy & Disposition

Begin octreotide, somatostatin, or terlipressin as soon as variceal hemorrhage is suspected and continue for several days after hemostasis according to local protocol. Give antibiotic prophylaxis, commonly ceftriaxone in advanced cirrhosis or areas with quinolone resistance, because infection prevention reduces rebleeding and mortality. Transfuse red cells conservatively in most patients, targeting a hemoglobin around 7 to 9 g/dL while individualizing for ongoing shock, cardiovascular disease, and active exsanguination. Avoid over-resuscitation because excessive portal pressure can worsen bleeding. Endoscopy should be performed after initial stabilization, generally within 12 hours. Use endoscopic variceal ligation for bleeding esophageal varices. Gastric varices may be treated with tissue adhesive, endovascular obliteration, TIPS, or other center-specific techniques. Failure of endoscopic and pharmacologic control requires rescue TIPS; a balloon tamponade device or self-expanding esophageal stent can serve as a short bridge in uncontrolled esophageal bleeding. Consider preemptive TIPS within 72 hours, ideally earlier, for selected high-risk patients such as Child-Pugh C 10 to 13 or Child-Pugh B with active bleeding at endoscopy, after assessing contraindications.

Epidemiology / Risk Factors

• Varices develop as a consequence of clinically significant portal hypertension, most commonly from cirrhosis.
• Risk of first bleeding rises with larger varices, red wale signs, and more advanced liver disease.
• Bacterial infection is common around variceal hemorrhage and contributes to rebleeding and mortality.
• Rebleeding risk is high after an index event without secondary prophylaxis.
• Gastric varices bleed less often than esophageal varices but can produce more severe hemorrhage.

Investigations

Early Orders (Abbrev.)

Pharmacology

Prognosis / Complications

• Short-term mortality remains substantial and is driven by hepatic reserve, shock, infection, renal failure, and failure of hemostasis.
• Early vasoactive therapy, antibiotics, endoscopic ligation, and risk-directed TIPS improve outcomes.
• Rebleeding is frequent without combined secondary prophylaxis.
• An episode of variceal hemorrhage represents hepatic decompensation and should prompt transplant evaluation when appropriate.
• Long-term outcome depends on control of portal hypertension and the underlying cause of liver disease.

Patient Education / Counseling

• Explain that variceal bleeding is caused by high pressure in portal veins and can recur even after successful banding.
• Take prescribed nonselective beta blocker exactly as directed after the acute episode and attend scheduled repeat endoscopy.
• Avoid NSAIDs and discuss all anticoagulant or antiplatelet medications with the liver and cardiovascular teams.
• Seek emergency care immediately for vomiting blood, black stool with weakness, fainting, or confusion.
• Discuss alcohol abstinence, viral hepatitis treatment, nutrition, transplant evaluation, and other cause-specific cirrhosis care.

Notes

Variceal bleeding is managed as a portal-pressure emergency, not simply as blood loss. Transfusion, vasoactive therapy, antibiotics, endoscopic ligation, and TIPS planning all affect the probability of rebleeding. The common preventable mistakes are waiting until endoscopy to start octreotide and antibiotics, over-transfusing a stable patient, and treating an elevated INR as though it were warfarin effect. Once the acute bleed is controlled, secondary prevention and transplant-oriented cirrhosis management become part of the same episode of care.

References

1. AASLD Practice Guidance on Portal Hypertension and Varices in Cirrhosis — Link